Reply: Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology

Sandro Alves¹, Guillaume Churlaud^{2

3}, David Klatzmann^{2

3}, Nathalie Cartier¹

Affiliations

¹ INSERM U1169/MIRCen CEA 92265 Fontenay aux Roses and Université Paris-Sud, Université Paris Saclay, 91400 Orsay, France.
² AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), F-75651, Paris, France.
³ Sorbonne Universités, UPMC Univ Paris 06, INSERM UMR-S 959, Immunology-Immunopathology-Immunotherapy, F-75013, Paris, France.

Comment

Sandro Alves et al. Brain. 2017.

. 2017 Jul 1;140(7):e40.

doi: 10.1093/brain/awx109.

Sandro Alves¹, Guillaume Churlaud^{2

3}, David Klatzmann^{2

3}, Nathalie Cartier¹

¹ INSERM U1169/MIRCen CEA 92265 Fontenay aux Roses and Université Paris-Sud, Université Paris Saclay, 91400 Orsay, France.
² AP-HP, Hôpital Pitié-Salpêtrière, Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (i2B), F-75651, Paris, France.
³ Sorbonne Universités, UPMC Univ Paris 06, INSERM UMR-S 959, Immunology-Immunopathology-Immunotherapy, F-75013, Paris, France.

No abstract available

Comment on

Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
Alves S, Churlaud G, Audrain M, Michaelsen-Preusse K, Fol R, Souchet B, Braudeau J, Korte M, Klatzmann D, Cartier N. Alves S, et al. Brain. 2017 Mar 1;140(3):826-842. doi: 10.1093/brain/aww330. Brain. 2017. PMID: 28003243
Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology.
Dansokho C, Aucouturier P, Dorothée G. Dansokho C, et al. Brain. 2017 Jul 1;140(7):e39. doi: 10.1093/brain/awx108. Brain. 2017. PMID: 28498909 No abstract available.